SNShaman Narayanasamy

Shaman Narayanasamy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shaman Narayanasamy has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrative analysis of the mouse cecal microbiome across diet, age, and weight in the diverse BXD population

    by Ziyun Zhou, Arianna Lamanna, Rashi Halder, Emeline Pansart, Shaman Narayanasamy, Besma Boussoufa, Thamila Kerkour, Paul Wilmes, Evan Williams

    Background: The gut microbiota adapts to and shapes the host’s metabolic state through affecting circulating metabolites and consequent gene regulatory networks, resulting in systemic influences in diverse organs via connections such as the gut–liver axis. Numerous variables such as diet, age, and host genetics modulate the composition of the gut microbiome, but their interactions and specific associative and mechanistic links to host molecular phenotypes remain incompletely unannotated. Integrated multi-omics approaches in genetically diverse populations offer an opportunity to dissect these interactions and identify predictive microbial signatures for host phenotypes, such as body weight and molecular associations with gene expression pathways in gut and liver. Results: We sequenced, aligned, and integrated the cecal metagenome, metatranscriptome, and host transcriptome from 232 mice across 175 distinct cohorts according to a low-fat chow diet (CD) or a high-fat diet (HF), four adult ages (between roughly 180 to 730 days of age), and 43 distinct genotypes (inbred BXD strains). Genetics and diet exerted the strongest influence on microbiota abundance and activity, followed by age. HF feeding significantly reduced diversity across all ages and all genotypes, altering > 300 species. Machine learning models based on microbial profiles reliably predicted body weight within dietary group ( AUC = 0.84 for CD, 0.79 for HF) and chronological age ( AUC = 0.84), with model performance of age prediction rising to 0.95 when integrating top microbial features with liver proteomics. Network analyses of expression data revealed links between genes, pathways, and specific microbes, including a negative association between cecal Ido1 expression and short-chain fatty acid (SCFA)-producing Lachnospiraceae, suggesting dietary fat may modulate host tryptophan metabolism through microbiota shifts. Conclusions: Whole metagenome and metatranscriptome sequencing approaches have massively expanded the landscape of microbiome analysis compared to earlier short-read 16S analyses. The resulting datasets quantify hundreds of uniquely identifiable microbes, which can be used to create sets of highly predictive microbial biomarkers for aging and obesity. When trained on controlled mouse populations, these results demonstrate that microbiome profiling can achieve high predictive capacity (AUC = 0.95 with multi-omics integration) for complex readouts such as age and body weight (AUC = 0.84), even considering genetic and dietary variation, establishing a framework for biomarker development. While at present many bacteria are still functionally unannotated at the species level, multi-omics approaches — including gene expression from the host tissues — provide insights into the functional associations of specific taxa in the microbiome.


  • Open Access

    Monitoring Cross-Border Dissemination of Antimicrobial Resistance (AMR) via Air Travel to Saudi Arabia: Formulation of Monitoring Strategies to Mitigate AMR Concerns

    by Changzhi Wang, Shaman Narayanasamy, Manal Shaabad, Ashraf Dallol, Sharif Hala, Pei-Ying Hong

    Antimicrobial resistance (AMR) is a global health challenge, and its dissemination can be accelerated by international air travel. Aircraft sewage, aggregating microbial material from global travelers, offers a unique surveillance opportunity for AMR at international entry points. However, specific AMR elements detected in aircraft sewage and how their relative abundance and transcriptional activity may be associated with flight characteristics such as flight duration or departure country remain unclear. This study analyzed 130 sewage samples from international flights arriving in Saudi Arabia across 27 countries. Metagenomic analyses revealed distinct AMR profiles in aircraft sewage compared to local municipal sewage, including elevated relative abundances of Enterococcus faecium and Staphylococcus aureus. Aircraft sewage harbored 51 antibiotic resistance genes (ARGs) that were not detected in local municipal sewage, predominantly carbapenem-resistant genes (e.g., blaNDM, blaVIM). Additionally, geographical origin of flights shaped AMR composition with lower ARG diversity observed from African-origin flights, whereas Asian and American flights exhibited enriched ARG profiles. Flight length affected AMR expression with long-haul flights (>3500 km) associated with elevated transcription levels. These findings demonstrated how international air travel facilitates the dissemination of AMR across regions and provided actionable insights to devise aircraft sewage surveillance strategies.


  • Open Access

    Integrative Analysis of the Mouse Cecal Microbiome Across Diet, Age, and Weight in the Diverse BXD Population

    by Ziyun Zhou, Arianna Lamanna, Rashi Halder, Emeline Pansart, Shaman Narayanasamy, Besma Boussoufa, Thamila Kerkour, Paul Wilmes, Evan Williams

    Background: The gut microbiota adapts to and shapes the host’s metabolic state through affecting circulating metabolites and consequent gene regulatory networks, resulting in systemic influences in diverse organs via connections such as the gut–liver axis. Numerous variables such as diet, age, and host genetics modulate the composition of the gut microbiome, but their interactions and specific associative and mechanistic links to host molecular phenotypes remain incompletely unannotated. Integrated multi-omics approaches in genetically diverse populations offer an opportunity to dissect these interactions and identify predictive microbial signatures for host phenotypes, such as body weight, and molecular associations with gene expression pathways in gut and liver. Results: We sequenced, aligned, and integrated the cecal metagenome, metatranscriptome, and host transcriptome from 232 mice across 175 distinct cohorts according to a low fat chow diet (CD) or a high-fat diet (HF), four adult ages (between roughly 180 to 730 days of age), and 43 distinct genotypes (inbred BXD strains). Genetics and diet exerted the strongest influence on microbiota abundance and activity, followed by age. HF feeding significantly reduced diversity across all ages and all genotypes, altering >300 species. Machine learning models based on microbial profiles reliably predicted body weight within dietary group (AUC = 0.84 for CD, 0.79 for HF) and chronological age (AUC = 0.84), with model performance rising of age prediction rising to 0.95 when integrating top microbial features with liver proteomics. Network analyses of expression data revealed links between genes, pathways, and specific microbes, including a negative association between cecal Ido1 expression and short-chain fatty acid (SCFA)-producing Lachnospiraceae, suggesting dietary fat may modulate host tryptophan metabolism through microbiota shifts. Conclusions: Whole metagenome and metatranscriptome sequencing approaches have massively expanded the landscape of microbiome analysis compared to earlier short-read 16S analyses. The resulting datasets quantify hundreds of uniquely identifiable microbes, which can be used to create sets of highly predictive microbial biomarkers for aging and obesity. When trained on controlled mouse populations, these results demonstrate that microbiome profiling can achieve high predictive capacity (AUC = 0.95 with multi-omics integration) for complex readouts such as age and body weight (AUC = 0.84), even considering genetic and dietary variation, establishing a framework for biomarker development. While at present many bacteria are still functionally unannotated at the species level, multi-omics approaches — including gene expression from the host tissues — provide insights into the functional associations of specific taxa in the microbiome.

  • Open Access

    Effectiveness of combined UV-C and bacteriophage approach over repeated cleaning cycles to alleviate membrane fouling of anaerobic bioreactors

    by Yevhen Myshkevych, Giantommaso Scarascia, Julie Sanchez Medina, Shaman Narayanasamy, Venkata Satagopam, Pei-Ying Hong


  • Open Access

    Figure 3 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Amiodarone decreases colony formation capacity in bladder cancer cell lines. Cells seeded in six-well plates were treated with increasing concentrations of amiodarone (0–5 μmol/L). After incubation for 7 to 10 days, the cells were stained with crystal violet, and the plates were scanned. A, Representative images of the colonies. B, Quantification of the colony number. Data are presented as the number of colonies related to the control and represent mean ± SEM from three independent experiments (one-way ANOVA with Dunnett’s multiple comparisons test; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).

  • Open Access

    Figure 5 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Amiodarone reduces bladder cancer tumor growth in vivo. Tumor growth in BFTC905-bearing NOD/SCID mice treated with 75 mg/kg of amiodarone. A, Tumor volume over time in control (n = 6) and amiodarone-treated (n = 6) tumor-bearing animals during a 3-week cycle treatment. Data represent mean ± SEM (Student t test; **, P < 0.01). B, Body weight of control and amiodarone-treated animals after 27 days of the experiment. Data represent mean ± SEM (Student t test; ****, P < 0.0001). C, Histologic analysis of liver, kidney, and heart sections derived from control and amiodarone-treated animals. Representative hematoxylin and eosin images are shown. D, Heatmap of the top 20 upregulated and top 20 downregulated genes identified by RNA-seq expression analysis of xenograft tumor samples. E, Top 10 significantly deregulated pathways identified by the RNA-seq analysis. F, Gene set enrichment analysis barcode plots for the top five significantly deregulated pathways. G, Heatmap showing the expression of the apoptosis-inducing ligand TNFSF10 and mitochondrially encoded genes of the electron transport chain. H, Dot plot representing the apoptosis gene set activity score derived from RNA-seq gene expression data. FC, fold change.

  • Open Access

    Figure 6 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Amiodarone inhibits mTOR and MAPK pathways. Cells were treated for 24 hours with increasing concentrations of amiodarone (0, 12.5, and 25 μmol/L), and the expression of the proteins AKT, mTOR, S6, and p44/42 MAPK, both phosphorylated (p-) and total, was analyzed by Western blot. GAPDH was used as a loading control. Blots are representative of three independent experiments. Quantification of the protein expression (normalized by GAPDH) is indicated under each corresponding band. Values are presented as expression related to the control. n.d., not determined.

  • Open Access

    Supplementary Table 1 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Differentially expressed genes (DEGs) between muscle invasive bladder cancer (MIBC) and non-muscle invasive bladder cancer (NBIMC).

  • Open Access

    Supplementary File 2 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Supplementary File 2 from Repurposing Amiodarone for Bladder Cancer Treatment

  • Open Access

    Supplementary Figure 1 from Repurposing Amiodarone for Bladder Cancer Treatment

    by Francisco J. Roa, Maria Roubelakis, Konstantinos Paschidis, Nils C.H. van Creij, Florian Handle, Manousos Makridakis, Shaman Narayanasamy, Irina-Afrodita Balaur, Aggeliki Tserga, Antonia Vlahou, et al.

    Supplementary Figure 1. Fluvoxamine, amiodarone, isradipine, and amodiaquine reduce viability in BC cell lines. A, UMUC3, HT1197, BFTC905, and RT112 cells were treated for 96 h with increasing concentrations (0–100 μM) of fluvoxamine (A), amiodarone (B), isradipine (C), and amodiaquine (D). Viability was evaluated using the CellTiter Cell Proliferation Assay. Concentration-response curves and IC50 values are shown. Data represent mean ± SEM from 3 independent experiments. h, hour; n.d., not determined.